Lucira Health Combo Flu/COVID-19 MDx Test Gets Regulatory Approval in Australia
The firm also announced the US launch of its combo test as it seeks a strategic or financial partner following Chapter 11 bankruptcy proceedings.
Lucira Health won't be the last COVID-19-focused firm to face bankruptcy, layoffs, or stock price declines, as "COVID cash" dries up, experts said.
BGI Genomics Gets Australian Regulatory Approval for Multiplexed SARS-CoV-2, Influenza Test
The RT-PCR-based test is designed to simultaneously detect and differentiate SARS-CoV-2, influenza A, and influenza B from throat swab samples.
Becton Dickinson Nabs FDA EUA for COVID-19, Influenza, RSV Test
The assay runs on the BD Max Molecular Diagnostic System and returns results in as little as two hours from a nasal or nasopharyngeal swab.
Simple HealthKit Raises $8M in Series A Round
The California startup sells PCR-based tests for respiratory and sexually transmitted diseases and said it will use the funding toward innovation and expanded sales of its products.